News
Market Data
Register for real-time alerts, custom portfolio, and market movers
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases.
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular...
Michelle Mellion, M.D., promoted to Chief Medical Officer Hayley Parker, Ph.D., promoted to Senior Vice President, Global Regulatory Affairs PepGen Inc. (Nasdaq: PEPG), a clinical-stage...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.15 | -6.49717514124 | 17.7 | 18.55 | 16.22 | 102424 | 17.07377661 | CS |
| 4 | -0.32 | -1.89685832839 | 16.87 | 18.72 | 15.79 | 171741 | 16.66225763 | CS |
| 12 | 4.61 | 38.6097152429 | 11.94 | 18.72 | 11.2614 | 102846 | 15.97138297 | CS |
| 26 | 9.72 | 142.313323572 | 6.83 | 18.72 | 6.51 | 117410 | 14.23700985 | CS |
| 52 | 9.1 | 122.147651007 | 7.45 | 18.72 | 3.72 | 86864 | 11.39882671 | CS |
| 156 | 0.95 | 6.08974358974 | 15.6 | 20 | 3.72 | 104637 | 11.67513719 | CS |
| 260 | 0.95 | 6.08974358974 | 15.6 | 20 | 3.72 | 104637 | 11.67513719 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
